In line with the observation that BCL9L could influence Wnt/β-catenin signalling in Cal29 cells, we investigated the effect of Wnt/β-catenin signalling inhibition by the specific inhibitor iCRT3 on BC cells Cal29 and T24. Here, BCL9L is linked to breast cancer.